Guobang Pharma Ltd. (SHA:605507)
26.18
-0.48 (-1.80%)
Mar 9, 2026, 3:00 PM CST
Guobang Pharma Market Cap
Guobang Pharma has a market cap or net worth of 14.48 billion as of March 9, 2026. Its market cap has increased by 28.84% in one year.
Market Cap
14.48B
Enterprise Value
13.23B
Revenue
5.94B
Ranking
n/a
PE Ratio
16.68
Stock Price
26.18
Market Cap Chart
Since August 2, 2021, Guobang Pharma's market cap has decreased from 26.21B to 14.48B, a decrease of -44.76%. That is a compound annual growth rate of -12.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 14.74B | 7.50% |
| Dec 31, 2025 | 13.71B | 19.12% |
| Dec 31, 2024 | 11.51B | 17.32% |
| Dec 29, 2023 | 9.81B | -33.66% |
| Dec 30, 2022 | 14.79B | -8.19% |
| Dec 31, 2021 | 16.11B | -38.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Jiuzhou Pharmaceutical | 14.83B |
| Shanghai Shyndec Pharmaceutical | 14.52B |
| ApicHope Pharmaceutical Group | 14.33B |
| Hybio Pharmaceutical | 15.19B |
| Shenzhen Hepalink Pharmaceutical Group | 15.29B |
| Guangdong Zhongsheng Pharmaceutical | 15.31B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 15.65B |
| Nanjing King-Friend Biochemical Pharmaceutical | 15.66B |